To Compare the Safety and Efficacy of Dapagliflozin Plus Metformin Versus Sitagliptin Plus Metformin for Treatment of Diabetes in Patients With Compensated and Stable Decompensated Cirrhosis

NCT06147518 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

240

Enrollment

OTHER

Sponsor class

Conditions

Compensated Cirrhosis
Decompensated Cirrhosis

Interventions

DRUG: Metformin
DRUG: Sitagliptin
DRUG: Dapagliflozin

Sponsor

Institute of Liver and Biliary Sciences, India